(Q43940972)
Statements
1 reference
Use of human ultralente as the basal insulin component in treatment of patients with IDDM. (English)
1 reference
Freeman SL
1 reference
O'Brien PC
1 reference
Rizza RA
1 reference
1 July 1991
1 reference
1 reference
Identifiers
1 reference